CCL2 and diabetic kidney disease: Blockade of CCR2, a chemokine receptor for ligands CCL2, 7, 8, 13, and 162, has been reported to improve insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice36.